ICL Group (ICL)
(Real Time Quote from BATS)
$4.60 USD
-0.01 (-0.22%)
Updated Jul 26, 2024 11:12 AM ET
3-Hold of 5 3
A Value C Growth C Momentum A VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
ICL 4.60 -0.01(-0.22%)
Will ICL be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for ICL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ICL
Zacks Industry Outlook Nutrien, ICL and Intrepid Potash
3 Top Fertilizer Stocks to Watch From a Promising Industry
ICL: What are Zacks experts saying now?
Zacks Private Portfolio Services
ICL Group (ICL) Beats Q1 Earnings and Revenue Estimates
Amerigo Resources (ARREF) Q1 Earnings Match Estimates
Analysts Estimate ICL Group (ICL) to Report a Decline in Earnings: What to Look Out for
Other News for ICL
ICL Announces Second Quarter 2024 Earnings Call
Barclays Sticks to Their Sell Rating for Icl (ICL)
ICL Group Strikes Major Potash Deal with China
ICL and Lavie Bio Leverage Artificial Intelligence to Make Significant Advancement in Development of Yield Increasing Bio-Stimulants
Warning: ICL is at high risk of cutting its dividend